Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Cefoxitin
Drug ID BADD_D00393
Description Cefoxitin is a semi-synthetic, broad-spectrum cepha antibiotic for intravenous administration. It is derived from cephamycin C, which is produced by Streptomyces lactamdurans.
Indications and Usage For the treatment of serious infections caused by susceptible strains microorganisms.
Marketing Status Prescription; Discontinued
ATC Code J01DC01
DrugBank ID DB01331
KEGG ID D02345
MeSH ID D002440
PubChem ID 441199
TTD Drug ID D02VFC
NDC Product Code 25021-110; 44567-245; 44567-246; 0143-9876; 25021-109; 0143-9878; 66288-4100; 44567-247; 25021-111; 0143-9877
Synonyms Cefoxitin | MK-306 | MK 306 | MK306 | Cefoxitin Sodium | Sodium, Cefoxitin | Mefoxin | Méfoxin | Mefoxitin
Chemical Information
Molecular Formula C16H17N3O7S2
CAS Registry Number 35607-66-0
SMILES COC1(C2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)O)NC(=O)CC3=CC=CS3
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Urinary tract disorder20.08.01.001--Not Available
Urticaria23.04.02.001; 10.01.06.001--
Vaginal infection21.14.02.002; 11.01.10.002--
Vaginal inflammation21.14.02.001--
Vomiting07.01.07.003--
Vulvovaginal candidiasis11.03.03.005; 21.14.02.003--Not Available
Tubulointerstitial nephritis20.05.02.002--Not Available
Blood urea nitrogen/creatinine ratio increased13.13.01.014--Not Available
Haemorrhage24.07.01.002--Not Available
Blood alkaline phosphatase increased13.04.02.004--
Induration08.01.03.020--Not Available
Renal impairment20.01.03.010--Not Available
Vulvovaginal mycotic infection11.03.05.004; 21.14.02.004--Not Available
Bone marrow failure01.03.03.005--
Acute kidney injury20.01.03.016--
Candida infection11.03.03.021--
The 3th Page    First    Pre   3    Total 3 Pages